- Recommendation ID
- TA254/2
- Question
- NICE recommends that a new model for multiple sclerosis is developed, ideally based on UK patient cohorts, which uses the best available evidence (including experience to date from the risk-sharing scheme) and includes all currently available treatments.
- Any explanatory notes
(if applicable) - None.
Source guidance details
- Comes from guidance
- Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis
- Number
- TA254
- Date issued
- April 2012
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |